Sandeep K Agarwal
Overview
Explore the profile of Sandeep K Agarwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
2445
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El-Halwagi A, Agarwal S
Best Pract Res Clin Rheumatol
. 2024 Jul;
38(4):101981.
PMID: 39068103
Systemic sclerosis (SSc) is a complex autoimmune disease that clinically manifests as progressive fibrosis of the skin and internal organs. Autoimmunity and endothelial dysfunction play important roles in the development...
2.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Rheumatol
. 2024 Jul;
76(8):1182-1200.
PMID: 38978310
Objective: We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs). Methods: We developed clinically relevant population, intervention, comparator, and...
3.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Care Res (Hoboken)
. 2024 Jul;
76(8):1051-1069.
PMID: 38973731
Objective: We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs). Methods: We developed clinically relevant population, intervention, comparator, and...
4.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Care Res (Hoboken)
. 2024 Jul;
76(8):1070-1082.
PMID: 38973729
Objective: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic...
5.
Johnson S, Bernstein E, Bolster M, Chung J, Danoff S, George M, et al.
Arthritis Rheumatol
. 2024 Jul;
76(8):1201-1213.
PMID: 38973714
Objective: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic...
6.
Ganugula R, Babalola K, Heyns I, Arora M, Agarwal S, Mohan C, et al.
Nano Today
. 2024 Jun;
57.
PMID: 38911970
One-third of systemic lupus erythematosus (SLE) patients experience various degrees of ocular manifestations, with immunosuppressants recommended as a treatment option. Targeted immune suppression via oral administration is challenging due to...
7.
Bruera S, Bowman S, Huang Y, Suarez-Almazor M, Lo G, Lopez-Olivo M, et al.
Arthritis Care Res (Hoboken)
. 2024 Apr;
76(9):1224-1231.
PMID: 38682616
Objective: The objective is to determine cervical cancer screening rates and factors associated with decreased cervical cancer screening in women with systemic lupus erythematosus (SLE). Methods: We conducted a cross-sectional...
8.
Bhatt H, Diwan R, Estevao I, Dong R, Smith J, Xiao C, et al.
J Control Release
. 2024 Apr;
370():110-123.
PMID: 38648957
Continuous and aberrant activation of myofibroblasts is the hallmark of pathological fibrosis (e.g., abnormal wound healing). The deposition of excessive extracellular matrix (ECM) components alters or increases the stiffness of...
9.
Chavula T, To S, Smith J, Pedroza M, Nimri J, Devaraj S, et al.
J Autoimmun
. 2024 Mar;
145:103197.
PMID: 38447248
Background And Objective: Understanding the regulation of efferocytosis by myeloid phagocytes is important in identifying novel targets in systemic lupus erythematosus (SLE). Cadherin-11 (CDH11), a cell adhesion molecule, is implicated...
10.
Huang Y, Agarwal S, Chen H, Chatterjee S, Johnson M, Aparasu R
Clin Ther
. 2023 Aug;
45(9):e177-e186.
PMID: 37573225
Purpose: Guidelines recommend using disease-modifying antirheumatic drugs (DMARDs) in combination with methotrexate (MTX) for patients with rheumatoid arthritis (RA) after monotherapy. Little is known about the real-world comparative effectiveness of...